Attention Deficit Hyperactivity Disorder Market: By Age Group (Children and Adults), By Disorders (Predominantly Inattentive, Predominantly Hyperactive-Impulsive, and Combined), and Region

Attention deficit hyperactivity disorder market size was valued at USD 15,836.5 million in 2023 and is poised to grow at a (CAGR) of 5.2% from 2024 to 2030. Attention-deficit hyperactivity disorder (ADHD) is characterized by symptoms of hyperactivity, impulsivity, and inattention, making it a recognized neurological condition. The exact cause of ADHD remains unidentified, though it is believed to result from a complex interplay of genetic predispositions, prenatal brain injuries, environmental factors such as exposure to toxins, and early developmental influences. The expansion of the market can be credited to the increasing demand for drugs used in treating attention deficit hyperactivity disorder (ADHD), spurred by the growing prevalence of ADHD worldwide. This trend is bolstered by heightened awareness of the disorder among healthcare providers and patients, alongside rising healthcare spending in different geographical areas.

According to a study published in the Italian Journal of Paediatrics in 2023, the global prevalence of ADHD in children aged 3 to 12 years is 7.6%, while it is 5.6% for those aged 12 to 18 years. The Forbes Health Report of 2023 indicates that approximately 129 million adolescents and children between 5 to 19 years old are living with ADHD. Nevertheless, stringent regulatory oversight and increasing medication costs, coupled with limited access to non-stimulant ADHD drugs, are expected to pose significant challenges to the growth of the attention-deficit hyperactivity disorder (ADHD) market in the upcoming years. Additionally, concerns about contraindications and side effects associated with ADHD medications are impacting the quality of life for patients, further hindering potential market expansion in the near term.

Attention Deficit Hyperactivity Disorder Market Key Developments

• In June 2023, Akili, a renowned digital medicine company, announced the launch of its over-the-counter version of the attention-improving game for adults suffering from attention deficit hyperactivity disorder.
• In January 2023, Inflow, a United Kingdom-based start-up that focuses on ADHD management through its applications, announced that it had raised US$ 11 million in a series A funding round led by Octopus Ventures along with other investors. The application helps patients manage ADHD through its Cognitive Behavioural Therapy-based support and the company intended to use the raised capital to expand its team and boost product development.